Drug Information
General Information | ||||||
---|---|---|---|---|---|---|
Drug ID |
DR00805
|
|||||
Drug Name |
GSK239512
|
|||||
Synonyms |
1-(6-((3-CYCLOBUTYL-2,3,4,5-TETRAHYDRO-1H-BENZO[D]AZEPIN-7-YL)OXY)PYRIDIN-3-YL)PYRROLIDIN-2-ONE; 2-Pyrrolidinone, 1-(6-((3-cyclobutyl-2,3,4,5-tetrahydro-1H-3-benzazepin-7-yl)oxy)-3-pyridinyl)-; 4I7U5C459M; 720691-69-0; AK171368; AKOS025291102; AS-42474; BDBM50444496; CHEMBL3092650; GSK-239512; GSK239512; J3.497.402K; KS-0000063Q; MolPort-035-776-189; SB16754; SCHEMBL167578; UNII-4I7U5C459M; YFRBKEVUUCQYOW-UHFFFAOYSA-N; ZINC3961802
|
|||||
Drug Type |
Small molecular drug
|
|||||
Structure |
|
|||||
3D MOL | 2D MOL | |||||
Formula |
C23H27N3O2
|
|||||
Canonical SMILES |
C1CC(C1)N2CCC3=C(CC2)C=C(C=C3)OC4=NC=C(C=C4)N5CCCC5=O
|
|||||
InChI |
InChI=1S/C23H27N3O2/c27-23-5-2-12-26(23)20-7-9-22(24-16-20)28-21-8-6-17-10-13-25(19-3-1-4-19)14-11-18(17)15-21/h6-9,15-16,19H,1-5,10-14H2
|
|||||
InChIKey |
YFRBKEVUUCQYOW-UHFFFAOYSA-N
|
|||||
Pharmaceutical Properties | Molecular Weight | 377.5 | Topological Polar Surface Area | 45.7 | ||
Heavy Atom Count | 28 | Rotatable Bond Count | 4 | |||
Hydrogen Bond Donor Count | 0 | Hydrogen Bond Acceptor Count | 4 | |||
XLogP |
3.4
|
|||||
PubChem CID | ||||||
TTD Drug ID |
If you find any error in data or bug in web service, please kindly report it to Dr. Yin and Dr. Li.